指南与共识分子诊断质量管理与危急值临床微生物

COVID-19分子诊断移动实验室指南

Guidelines for Mobile Laboratories for Molecular Diagnostic Testing of COVID-19.
指南 / 共识 · Ann Lab Med · 2022-01-01

随着COVID-19快速传播,移动实验室需求增加,但缺乏操作、维护或质量控制指南。本文基于专家意见和实验室认可检查表,提供移动实验室操作、管理和质量控制指南,专门针对COVID-19分子诊断检测的实施与执行。

要点

  • 指南涵盖设施、术前评估、PCR检测、内外质控、样本处理、报告、人员、生物安全等级和安全管理。
  • 适用于常规情况及公共卫生危机和紧急状态下的移动实验室维护与运行。
  • 指南主要基于专家意见和实验室认可检查表,非系统评价。

核心结论

  • 提供了移动实验室操作、管理和质量控制的实践指南,特别针对COVID-19分子诊断检测。

研究设计与样本

  • 基于专家意见和实验室认可检查表的实践指南。

临床怎么用

  • 可用于常规及公共卫生危机和紧急状态下移动实验室的维护与运行。

局限性

  • 指南主要基于专家意见和实验室认可检查表,未报告系统评价或原始研究数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

With the rapid spread of the coronavirus disease (COVID-19), the need for rapid testing and diagnosis and consequently, the demand for mobile laboratories have increased. Despite this need, there are no clear guidelines for the operation, maintenance, or quality control of mobile laboratories. We provide guidelines for the operation, management, and quality control of mobile laboratories, and specifically for the implementation and execution of COVID-19 molecular diagnostic testing. These practical guidelines are primarily based on expert opinions and a laboratory accreditation inspection checklist. The scope of these guidelines includes the facility, preoperative evaluation, PCR testing, internal and external quality control, sample handling, reporting, laboratory personnel, biosafety level, and laboratory safety management. These guidelines are useful for the maintenance and operation of mobile laboratories not only in normal circumstances but also during public health crises and emergencies.

来源:Ann Lab Med,查看原文。版权归原作者所有。

引用

  1. Roh KH, Hong KH, Nam MH, et al. Guidelines for Mobile Laboratories for Molecular Diagnostic Testing of COVID-19. Ann Lab Med. 2022. PMID: 35470270. doi:10.3343/alm.2022.42.5.507

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。